Scleraxis and fibrosis in the pressure-overloaded heartRaghu S. Nagalingam, Michael P. Czubryt, Zamaneh Kassiri et al.|European Heart Journal|2022Cited by 51
Elimination of endogenous high molecular weight FGF2 prevents pressure-overload-induced systolic dysfunction, linked to increased FGFR1 activity and NR1D1 expressionNavid Koleini, Elissavet Kardami, Barbara E. Nickel et al.|Cell and Tissue Research|2021Cited by 10
Scleraxis as a prognostic marker of myocardial fibrosis in hypertrophic cardiomyopathy (SPARC) studyAntonia Zhu, Davinder S. Jassal, Hilary Bews et al.|Canadian Journal of Physiology and Pharmacology|2020Cited by 4
Changes in gene expression caused by genetic elimination of high molecular weight FGF2 are associated with prevention of stress‐induced cardiac systolic dysfunctionElissavet Kardami, Peter A. Cattini, Navid Koleini et al.|The FASEB Journal|2020Cited by 2
Abstract 19631: Scleraxis Regulates Pressure Overload-Induced Cardiac FibrosisRaghu S. Nagalingam, Michael P. Czubryt, David Cheung et al.|Circulation|2017Cited by 0